 SAN DIEGO, Sept. 16, 2021 GLOBE NEWSWIRE -- eFFECTOR Therapeutics NASDAQ: EFTR, a leader in the development of selective translation regulator inhibitors STRIs for the treatment of cancer, today announced that company management will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference at 2:40 p.m. ET on Tuesday, September 28, 2021. eFFECTOR will also host investor meetings throughout the conference. 